TickerFacts.

Ernexa Therapeutics Inc. (ERNA): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2022-11-14; 1-for-15, first reflected in a filing dated 2025-08-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

7.85M
As of 2025-12-31
1.17M
As of 2026-06-30
92.37M2010-12-31: 60.8K2011-12-31: 60.9K2012-12-31: 71.12M2013-12-31: 78.65M2014-12-31: 92.37M2015-12-31: 1.85M2016-12-31: 2.26M2017-12-31: 2.52M2018-12-31: 2.88M2019-12-31: 2.90M2020-12-31: 2.97M2021-12-31: 2.60M2022-12-31: 5.13M2023-12-31: 5.41M2024-12-31: 3.43M2025-12-31: 7.85M7.85M
2010-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-317.85M+129.2%2026-03-13, Balance as of period end
2024-12-313.43Mn/c2026-03-13, Balance as of period end
2023-12-315.41M+5.5%2025-03-12, Balance as of period end
2022-12-315.13Mn/c2024-03-14, Balance as of period end
2021-12-312.60Mn/c2023-03-20, Balance as of period end
2020-12-312.97M+2.2%2021-03-11, Balance as of period end
2019-12-312.90M+0.9%2021-03-11, Balance as of period end
2018-12-312.88M+14.0%2020-03-19, Balance as of period end
2017-12-312.52M+11.5%2019-03-22, Balance as of period end
2016-12-312.26M+22.3%2018-03-09, Balance as of period end
2015-12-311.85M-98.0%2017-03-09, Balance as of period end
2014-12-3192.37M+17.4%2016-03-15, Balance as of period end
2013-12-3178.65M+10.6%2015-03-27, Balance as of period end
2012-12-3171.12Mn/m2014-03-31, Balance as of period end
2011-12-3160.9K+0.3%2013-03-29, Balance as of period end
2010-12-3160.8Kn/a2012-03-30, Balance as of period end